These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20615913)

  • 1. Novel role of Egr-1 in nicotine-related neointimal formation.
    Vazquez-Padron RI; Mateu D; Rodriguez-Menocal L; Wei Y; Webster KA; Pham SM
    Cardiovasc Res; 2010 Nov; 88(2):296-303. PubMed ID: 20615913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking induces vascular proliferative disease through the activation of Egr-1.
    Fukuda N
    Cardiovasc Res; 2010 Nov; 88(2):207-8. PubMed ID: 20833649
    [No Abstract]   [Full Text] [Related]  

  • 3. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
    Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STIM-1 and ORAI-1 channel mediate angiotensin-II-induced expression of Egr-1 in vascular smooth muscle cells.
    Simo-Cheyou ER; Tan JJ; Grygorczyk R; Srivastava AK
    J Cell Physiol; 2017 Dec; 232(12):3496-3509. PubMed ID: 28105751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
    Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
    Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
    Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation.
    Gennaro G; Ménard C; Giasson E; Michaud SE; Palasis M; Meloche S; Rivard A
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):204-10. PubMed ID: 12588760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal formula HMC05 prevents human aortic smooth muscle cell migration and proliferation by inhibiting the ERK1/2 MAPK signaling cascade.
    Kang YH; Yang IJ; Shin HM
    J Nat Med; 2012 Jan; 66(1):177-84. PubMed ID: 21833774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
    Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.
    Torella D; Gasparri C; Ellison GM; Curcio A; Leone A; Vicinanza C; Galuppo V; Mendicino I; Sacco W; Aquila I; Surace FC; Luposella M; Stillo G; Agosti V; Cosentino C; Avvedimento EV; Indolfi C
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2015-25. PubMed ID: 19783773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10.
    Tsihlis ND; Oustwani CS; Vavra AK; Jiang Q; Keefer LK; Kibbe MR
    Cell Biochem Biophys; 2011 Jun; 60(1-2):89-97. PubMed ID: 21448667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.
    Wang YC; Cui XB; Chuang YH; Chen SY
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1352-1360. PubMed ID: 28473442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized LDL promotes the mitogenic actions of Chlamydia pneumoniae in vascular smooth muscle cells.
    Chahine MN; Deniset J; Dibrov E; Hirono S; Blackwood DP; Austria JA; Pierce GN
    Cardiovasc Res; 2011 Dec; 92(3):476-83. PubMed ID: 22072707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury.
    Huang C; Chang JS; Xu Y; Li Q; Zou YS; Yan SF
    Atherosclerosis; 2010 Sep; 212(1):123-30. PubMed ID: 20594553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat.
    Han W; Liu GN
    Life Sci; 2010 Feb; 86(7-8):234-43. PubMed ID: 20025889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.